from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1536/ileS

LFCtreatmentdescriptionclass of inhibitor

-1.967

Amikacinug/mL Amikacintranslation

-1.183

Cap5-10ug/mL Capreomycintranslation

-1.689

Rox10-50 ug/mL Roxithromycintranslation

-1.128

SM2-5 ug/mL Streptomycintranslation

-2.989

Tet5-10 ug/mL Tetracyclinetranslation

0.672

Rif0.2-5ug/mL Rifampicintranscription

1.167

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.385

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.796

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.464

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.383

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.692

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.458

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.465

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.691

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-1.124

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.013

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.472

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.353

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.274

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.751

KCN5-20 ug/mL Potassium cyaniderespiration

-0.089

NaN30.2-2 mM Sodium aziderespiration

-1.354

Nigericin50 uM Nigericinrespiration

0.471

TRC10-150 ug/mL Triclosanrespiration

0.719

TRZ10-25 ug/mL Thioridazinerespiration

-0.269

Valinomycin0.5-10 uM Valinomycinrespiration

-1.362

ZnSO42 mM ZnSO4respiration

0.184

menadione6-10 ug/mL Menadionerespiration

0.135

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.564

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.190

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.765

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.416

NRP_1Non-replicating persistence stage 1dosRassociated

0.033

Amp0.2mg/mL AmpicillincellWall

-0.276

Cephalexin20-100 ug/mL CephalexincellWall

-0.623

Cerulenin0.32-5 ug/mL CerulenincellWall

1.227

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.326

EMB10-20 ug/mL EthambutolcellWall

-1.532

Eta12-40 ug/mL EthionamidecellWall

-1.938

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.578

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.631

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.184

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.828

BZA0.12 mg/mL BenzamidearomaticAmides

0.602

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.371

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.564

H2O24 mM hydrogen peroxideDNAdamaging

-0.305

Levo10 ug/mL LevofloxacinDNAdamaging

0.495

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.186

Novobiocin10 ug/mL NovobiocinDNAdamaging

-1.030

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.192

UVUV-irradiationDNAdamaging

0.178

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.638

Antimycin12.5-50 ug/mL Antimycin A?

-1.043

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.110

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.101

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.936

PA8240.2-2 ug/mL PA-824?

0.308

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.156

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.742

Verapamil50 uM Verapamil?

-0.679

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.767

methoxatin10-20 ug/mL Methoxatin?